PolyNovo Limited
Research PolyNovo Limited (PNV.AX) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerPNV.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Financial periodFY2026
- RevenueAUD 143.71M
- Revenue growth12.9%
- Net incomeAUD 7.34M
- Free cash flowAUD 9.31M
- Gross margin89.4%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 143.71M | AUD 7.34M | AUD 9.31M | 89.4% | 0.01 | AUD 35.42M | AUD 17.61M | AUD 90.70M |
| FY2025 | AUD 127.24M | AUD 13.21M | -AUD 10.78M | 95.9% | 0.02 | AUD 33.54M | AUD 17.14M | AUD 83.26M |
| FY2024 | AUD 103.19M | AUD 5.26M | AUD 786.00K | 94.7% | 0.01 | AUD 45.91M | AUD 15.38M | AUD 72.12M |
| FY2023 | AUD 65.24M | -AUD 4.92M | -AUD 8.14M | 93.2% | -0.01 | AUD 46.85M | AUD 16.04M | AUD 65.38M |
| FY2022 | AUD 41.44M | -AUD 1.19M | -AUD 2.55M | 94.7% | 0 | AUD 6.10M | AUD 10.99M | AUD 17.72M |
About PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What does PolyNovo Limited do?
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014.